Inhibrx Biosciences Inc. focuses on the development of a diverse pipeline of antibody therapeutic candidates aimed at addressing unmet medical needs in oncology, inflammatory diseases, and infectious diseases.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!